Join our daily newsletter At The Bell to receive exclusive market insights
This week the Wealth Within team talk about Lynas Rare Earths (LYC) which has reported 22% higher sales revenue from the same time last year and strong production volumes.
Having said that, the revenue is down from the December quarter.
Wealth Within senior analyst Fil Tortevski shows the charting methodology and macro factors that may suggest Lynas is lining up for a ‘huge opportunity’.
“In light of what is happening around the world with the rare earths, there is a huge opportunity,” he said.
“Lynas is – bar China – the biggest rare earth player out there. So, this could open up a whole bunch of new supply chains for the stock.”
Wealth Within’s chief analyst Dale Gillham says LYC trading volumes have increased immensely and more consistently since 2017-18.
Hear their full analysis in this week’s Hot Stock Tips show.
Lynas last traded at $8.60.
Join the discussion: See what HotCopper users are saying about Lynas Rare Earths and be part of the conversations that move the markets.
Telix troubles
The next stock discussed in this week’s Wealth Within video, is Telix Pharmaceuticals (ASX:TLX), which plunged some 8% after the U.S FDA delayed approvals for Telix’s new drug for imaging rare brain cancer – despite prior approval.
So is it time to take profits – given the stock has tripled in vertical-type rises in just over a year?
Wealth Within’s Gillham and Tortevski discuss what’s likely to happen, based on chart analysis.
Despite the news from the FDA, Telix last traded at $26.95.
Join the discussion: See what HotCopper users are saying about TLX.
Taking a hard landing
Flight Centre Travel Group (ASX:FLT) is the third stock discussed today.
It has downgraded its FY25 profit guidance due to weaker U.S. travel demand. It has also announced a $200 million share buyback and cost-cutting measures.
Mr Tortevski said while it might look like a ‘sell right now’, it could present opportunities if the company makes the right structural changes.
Mr Gillham added: “It looks all doom and gloom downgrading profits, but that whole buyback is good capital management by the company’.
“That’s a great thing that it’s buying back shares, so I love what it’s doing.
“Obviously the times are a little bit tougher for them at the moment, but as we see interest rates come down we’ll see the economy being stimulated, travel will pick up.
“This is a stock that you would watch.
“Maybe in six months time it will give you a great buy, that once in a life time opportunity to pick up a really good stock while the news is a little bit bad on it.”
FLT last traded at $12.73.
Join the discussion: See what HotCopper users are saying about FLT.
Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also the author of Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in bookstores and online at www.wealthwithin.com.au
The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.
